Claire Forde

478 total citations
22 papers, 203 citations indexed

About

Claire Forde is a scholar working on Genetics, Molecular Biology and Physiology. According to data from OpenAlex, Claire Forde has authored 22 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Claire Forde's work include BRCA gene mutations in cancer (9 papers), Cancer Genomics and Diagnostics (5 papers) and DNA Repair Mechanisms (4 papers). Claire Forde is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Cancer Genomics and Diagnostics (5 papers) and DNA Repair Mechanisms (4 papers). Claire Forde collaborates with scholars based in United Kingdom, United States and Italy. Claire Forde's co-authors include Simon Lal, D. Gareth Evans, Fiona Lalloo, Emma R. Woodward, K. Farrer, B. Blackett, George J. Burghel, Jacqueline A. James, David P. Boyle and Perry Maxwell and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Medical Genetics.

In The Last Decade

Claire Forde

19 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Forde United Kingdom 7 69 56 50 38 36 22 203
Raees Tonse India 10 58 0.8× 115 2.1× 95 1.9× 20 0.5× 12 0.3× 39 292
Aurélie Cabrespine France 10 60 0.9× 68 1.2× 95 1.9× 77 2.0× 55 1.5× 26 310
Insa Schiffmann Germany 7 111 1.6× 50 0.9× 72 1.4× 16 0.4× 11 0.3× 16 265
Breton Roussel United States 8 62 0.9× 93 1.7× 82 1.6× 81 2.1× 8 0.2× 21 327
Sandrine Oziel-Taïeb France 7 27 0.4× 27 0.5× 97 1.9× 84 2.2× 23 0.6× 19 247
Amalia S. Lehmann United States 7 116 1.7× 72 1.3× 116 2.3× 11 0.3× 10 0.3× 9 309
Meredith Kato United States 8 40 0.6× 27 0.5× 59 1.2× 7 0.2× 20 0.6× 17 415
H. van den Berg Netherlands 6 36 0.5× 76 1.4× 54 1.1× 37 1.0× 23 0.6× 12 303
N. Gebbia Italy 8 33 0.5× 68 1.2× 116 2.3× 36 0.9× 8 0.2× 25 244
Utku Oflazoğlu Türkiye 11 58 0.8× 44 0.8× 154 3.1× 73 1.9× 5 0.1× 41 312

Countries citing papers authored by Claire Forde

Since Specialization
Citations

This map shows the geographic impact of Claire Forde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Forde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Forde more than expected).

Fields of papers citing papers by Claire Forde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Forde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Forde. The network helps show where Claire Forde may publish in the future.

Co-authorship network of co-authors of Claire Forde

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Forde. A scholar is included among the top collaborators of Claire Forde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Forde. Claire Forde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kershaw, Christopher J., Leigh Demain, George J. Burghel, et al.. (2025). Whole Genome Sequencing to Identify Novel Germline Fumarate Hydratase Mutation in Child With Bilateral Renal Cell Carcinoma. Clinical Genetics. 107(6). 702–704.
2.
Rajan, Neil, Helen Hatcher, Andrea Napolitano, et al.. (2025). UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants. Journal of Medical Genetics. 62(9). 559–565. 1 indexed citations
3.
Morgan, Robert D., George J. Burghel, Hélene Schlecht, et al.. (2024). Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene. Genetics in Medicine. 26(10). 101230–101230. 5 indexed citations
4.
Evans, D. Gareth, Robert D. Morgan, Emma J. Crosbie, et al.. (2024). Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy. Genetics in Medicine. 26(9). 101172–101172. 1 indexed citations
5.
Evans, D. Gareth, Kate Green, George J. Burghel, et al.. (2024). Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre. Familial Cancer. 23(2). 187–195. 2 indexed citations
6.
Evans, D. Gareth, George J. Burghel, Sacha J. Howell, et al.. (2024). Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond BRCA2, BRCA1 and CHEK2. Journal of Medical Genetics. 61(9). 853–855. 1 indexed citations
7.
Shaw, Simon, et al.. (2023). Oxygen utilisation in patients on prolonged parenteral nutrition; a case-controlled study. Clinical Nutrition ESPEN. 56. 152–157. 2 indexed citations
8.
Evans, D. Gareth, George J. Burghel, Hélene Schlecht, et al.. (2023). Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancer. Journal of Medical Genetics. 60(10). 974–979. 4 indexed citations
9.
10.
Evans, D. Gareth, Elke M. van Veen, George J. Burghel, et al.. (2022). Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers. Journal of Medical Genetics. 60(8). 740–746. 2 indexed citations
11.
Farrer, K., et al.. (2022). An evaluation of plasma vitamin C concentrations in individuals requiring home parenteral nutrition. Journal of Human Nutrition and Dietetics. 35(5). 895–900. 2 indexed citations
12.
Woodward, Emma R., Elke M. van Veen, Claire Forde, et al.. (2021). Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer. Genetics in Medicine. 23(10). 1969–1976. 9 indexed citations
13.
Brennan, Bernadette, Alastair Brown, Claire Forde, et al.. (2020). Virtual consultations: Providing alternative ways of supporting patients with inherited bleeding disorders. Haemophilia. 27(4). e498–e501.
14.
Forde, Claire, Kate Brunstrom, Emma R. Woodward, et al.. (2020). Uptake of pre-symptomatic testing for BRCA1 and BRCA2 is age, gender, offspring and time-dependent. Journal of Medical Genetics. 58(2). 74–78. 5 indexed citations
15.
Forde, Claire, Andrew T. King, Scott Rutherford, et al.. (2020). Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution. Neuro-Oncology. 23(7). 1113–1124. 21 indexed citations
16.
Forde, Claire, Derek Lim, George J. Burghel, et al.. (2019). Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals. European Urology Oncology. 3(6). 764–772. 51 indexed citations
17.
Buckley, Niamh E., Claire Forde, Darragh G. McArt, et al.. (2016). Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatment. Scientific Reports. 6(1). 23383–23383. 38 indexed citations
18.
Hvas, Christian Lodberg, K. Farrer, B. Blackett, et al.. (2015). Introduction of a complete nutrition support team increases appropriate parenteral nutrition use and reduces its complications. Clinical Nutrition ESPEN. 10(5). e203–e203. 1 indexed citations
19.
Hvas, Christian Lodberg, K. Farrer, B. Blackett, et al.. (2014). Quality and safety impact on the provision of parenteral nutrition through introduction of a nutrition support team. European Journal of Clinical Nutrition. 68(12). 1294–1299. 28 indexed citations
20.
Forde, Claire. (2012). Efficiency: Prescription for challenging times.. PubMed. 122(6291). 30–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raees Tonse Breakdown of academic impact, for papers by Aurélie Cabrespine Breakdown of academic impact, for papers by Insa Schiffmann Breakdown of academic impact, for papers by Breton Roussel Breakdown of academic impact, for papers by Sandrine Oziel-Taïeb Breakdown of academic impact, for papers by Amalia S. Lehmann Breakdown of academic impact, for papers by Meredith Kato Breakdown of academic impact, for papers by H. van den Berg Breakdown of academic impact, for papers by N. Gebbia Breakdown of academic impact, for papers by Utku Oflazoğlu
Rankless by CCL
2026